SCHEMBL5873189

SCHEMBL5873189

O=C(c1ccc(Br)cc1)C(Br)C(Br)c1ccc(Br)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CYP1A2 P05177 2/20 0.44
ALDH1A1 P00352 2/20 0.44
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
GSK3B P49841 3/20 0.42
LMNA P02545 3/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
OGG1 O15527 1/20 0.41
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5873202 0.91 GSK3B (0.56) CES2CES1CA1CA2CYP1A2
SCHEMBL5873117 0.90 LMNA (0.50) CES2CES1CA1CA2CYP1A2
SCHEMBL28795688 0.90 MEN1 (0.50) CES2CES1CYP1A2ALDH1A1KMT2A
SCHEMBL7734235 0.87 CES2 (0.56) CES2CES1CA1CA2CYP1A2
SCHEMBL1799408 0.86 PARP1 (0.41) CES2CES1CA1CA2CYP1A2
SCHEMBL1795647 0.82 PARP1 (0.49) CYP1A2ALDH1A1KMT2AMEN1GSK3B
SCHEMBL1796450 0.80 GSK3B (0.66) CA1CA2CYP1A2ALDH1A1KMT2A
SCHEMBL20159736 0.79 CES2 (0.48) CES2CES1CA1CA2CYP1A2
SCHEMBL978025 0.79 TDP1 (0.57) CES2CES1CYP1A2ALDH1A1KMT2A
SCHEMBL27998797 0.78 CYP1A2 (0.45) CES2CES1CYP1A2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7067702-B2 Process for preparing vinyl substituted beta-diketones THE JOHNS HOPKINS UNIVERSITY (US) 2006-06-27 US disclosed
US-20060069288-A1 Process for preparing vinyl substituted beta-diketones THE JOHNS HOPKINS UNIVERSITY 2006-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069288-A1 Process for preparing vinyl substituted beta-diketones VRK1, VRK2, DEK CES2 2479/4885CES1 2307/4885CA1 3845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.